Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study
- PMID: 1283363
- PMCID: PMC11567239
- DOI: 10.1007/BF00711237
Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study
Abstract
1. Concentrations of the neurotransmitter amines noradrenaline (NA), dopamine (DA), and 5-hydroxytryptamine (5-HT) and the acid metabolites homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were determined in four regions of postmortem brains of demented patients with or without Alzheimer's disease (AD). 2. NA was deficient in the temporal cortex (BA 21) of AD, but not of non-AD, patients. 3. Caudate, in particular, had an impaired dopaminergic system in AD patients, with low HVA levels. 4. In all regions investigated [amygdala, caudate, putamen, temporal cortex (BA 21)] 5-HT was significantly depleted in AD patients, and 5-HIAA was also depleted in amygdala and caudate. 5. These results indicate that neurotransmitter systems other than cholinergic systems are also widely affected in AD and suggest that these deficits may also play an important role in determining the symptomatology of AD.
Similar articles
-
Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.Neurology. 1993 Oct;43(10):1927-34. doi: 10.1212/wnl.43.10.1927. Neurology. 1993. PMID: 8105420
-
Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.J Neurochem. 1984 Aug;43(2):388-93. doi: 10.1111/j.1471-4159.1984.tb00913.x. J Neurochem. 1984. PMID: 6204013
-
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.Brain Res. 1987 Jan 20;401(2):231-8. doi: 10.1016/0006-8993(87)91408-9. Brain Res. 1987. PMID: 2434191
-
Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.Neurosci Biobehav Rev. 2013 Sep;37(8):1363-79. doi: 10.1016/j.neubiorev.2013.05.008. Epub 2013 May 24. Neurosci Biobehav Rev. 2013. PMID: 23707776 Review.
-
Seasonal and circadian monoamine variations in human brains examined post mortem.Acta Psychiatr Scand Suppl. 1980;280:75-85. Acta Psychiatr Scand Suppl. 1980. PMID: 6157305 Review. No abstract available.
Cited by
-
Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's disease.Neural Plast. 2015;2015:825157. doi: 10.1155/2015/825157. Epub 2015 Mar 26. Neural Plast. 2015. PMID: 25883808 Free PMC article.
-
Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide.Int J Mol Sci. 2021 May 31;22(11):5896. doi: 10.3390/ijms22115896. Int J Mol Sci. 2021. PMID: 34072751 Free PMC article.
-
Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.Neurobiol Aging. 2023 May;125:98-108. doi: 10.1016/j.neurobiolaging.2023.01.016. Epub 2023 Feb 1. Neurobiol Aging. 2023. PMID: 36889122 Free PMC article.
-
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.Brain. 2009 Feb;132(Pt 2):392-401. doi: 10.1093/brain/awn326. Epub 2009 Jan 19. Brain. 2009. PMID: 19153152 Free PMC article.
-
Systemic Modulators: Potential Mechanism for the 5-HT System to Mediate Exercise Amelioration in Alzheimer's Disease.Aging Dis. 2024 Sep 30;16(5):2770-2802. doi: 10.14336/AD.2024.0834. Aging Dis. 2024. PMID: 39500357 Free PMC article. Review.
References
-
- Arai, H., Kosaka, K., and Iizuka, R. (1984). Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.J. Neurochem.43388–393. - PubMed
-
- Baker, G. B., and Reynolds, G. P. (1989). Biogenic amines and their metabolites in Alzheimer's disease: Noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.Neurosci. Lett.100335–339. - PubMed
-
- Bondareff, W., Mountjoy, C. Q., and Roth, M. (1981). Selective loss of neurons of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.Lancet,1783–784. - PubMed
-
- Bowen, D. M., Allen, S. J., Benton, J. S., Goodhardt, M. J., Haan, E. A., Palmer, A. M., Sims, N. R., Smith, C. C. T., Spillane, J. A., Esiri, M. M., Neary, D., Snowdon, J. S., Wilcock, G. K., and Davison, A. N. (1983). Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.J. Neurochem.41266–272. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical